Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Givinostat |
Synonyms | |
Therapy Description |
Givinostat (ITF2357) is a pan-HDAC inhibitor, which promotes cell-cycle arrest and apoptosis of tumor cells (PMID: 24648290, PMID: 32047238, PMID: 31346710). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Givinostat | ITF2357 | HDAC Inhibitor 45 | Givinostat (ITF2357) is a pan-HDAC inhibitor, which promotes cell-cycle arrest and apoptosis of tumor cells (PMID: 24648290, PMID: 32047238, PMID: 31346710). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06093672 | Phase III | Givinostat Hydroxyurea | Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera (GIV-IN PV) | Recruiting | USA | POL | NLD | ITA | ISR | IRL | HUN | HRV | GBR | FRA | ESP | DEU | BGR | AUT | 1 |